Inventor · disambiguated record
Ann Louise Walker
Also filed as: WALKER ANN L · WALKER ANN LOUISE
36 granted patents·10 pending applications·340 citations·filing 1995–2022
97Inventor score
Files withGLAXO GROUP LTD15GLAXOSMITHKLINE IP DEV LTD8SMITHKLINE BEECHAM CORP5GLAXOSMITHKLINE LLC3ASTON NICOLA MARY2
Top patents by PatentIndex Score
46 records- 0192US7125898B2Nicotinamide derivatives useful as p38 inhibitors.SMITHKLINE BEECHAM CORP·Filed 2003·Granted Oct 24, 2006·39 cites·15 claims
- 0290US7309800B2Biphenylcarboxylic amide derivatives as p38 kinase inhibitorsGLAXO GROUP LTD·Filed 2006·Granted Dec 18, 2007·17 cites·13 claims
- 0389US7514456B2Nicotinamide derivatives useful as p38 inhibitorsSMITHKLINE BEECHAM CORP·Filed 2006·Granted Apr 7, 2009·9 cites·10 claims
- 0488US9315487B2Tetrahydroquinoline derivatives useful as bromodomain inhibitorsAMANS DOMINIQUE·Filed 2012·Granted Apr 19, 2016·16 cites·8 claims
- 0587US7151118B2Biphenylcarboxylic amide derivatives as p38-kinase inhibitorsGLAXO GROUP LTD·Filed 2002·Granted Dec 19, 2006·27 cites·15 claims
- 0686US7166623B22′-Methyl-5′-(1,3,4-oxadiazol-2-yl)-1,1′-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitorsGLAXO GROUP LTD·Filed 2002·Granted Jan 23, 2007·22 cites·14 claims
- 0785US6541490B1Bipyridine manganese complexesEUKARION INC·Filed 2000·Granted Apr 1, 2003·25 cites·2 claims
- 0884US7709506B2Nicotinamide derivatives useful as p38 inhibitorsGLAXOSMITHKLINE LLC·Filed 2006·Granted May 4, 2010·5 cites·34 claims
- 0983US7732622B2Naphthalene derivativesGLAXO GROUP LTD·Filed 2008·Granted Jun 8, 2010·5 cites·3 claims
- 1082US7208629B25′-Carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitorsGLAXO GROUP LTD·Filed 2002·Granted Apr 24, 2007·20 cites·17 claims
- 1181US7384963B22′-Methyl-5-(1,3,4-oxadiazol-2-yl)1, 1′-biphenyl-4-carboxaide derivatives and their use as p38 kinaseGLAXO GROUP LTD·Filed 2002·Granted Jun 10, 2008·15 cites·11 claims
- 1280US10039755B22-(azaindol-2-yl) benzimidazoles as PAD4 inhibitorsGLAXO GROUP LTD·Filed 2017·Granted Aug 7, 2018·2 cites·9 claims
- 1380US7687532B2Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of I.A. rheumatoid arthritisGLAXOSMITHKLINE LLC·Filed 2005·Granted Mar 30, 2010·5 cites·20 claims
- 1480US7183297B2Biphenyl-derivatives as p38-kinase inhibitorsGLAXO GROUP LTD·Filed 2002·Granted Feb 27, 2007·14 cites·21 claims
- 1579US11352372B2Benzimidamides compounds comprising an oxaborinin ringINST NAT SANTE RECH MED·Filed 2019·Granted Jun 7, 2022·2 cites·10 claims
- 1679US9932328B23-(6-alkoxy-5-chlorobenzo[d]isoxazol-3-yl)propanoic acid useful as kynurenine monooxygenase inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Granted Apr 3, 2018·2 cites·16 claims
- 1779US9833449B22-(azaindol-2-yl) benzimidazoles as PAD4 inhibitorsGLAXO GROUP LTD·Filed 2016·Granted Dec 5, 2017·2 cites·20 claims
- 1879US9518054B22-(azaindol-2-yl) benz imidazoles as PAD4 inhibitorsGLAXO GROUP LTD·Filed 2015·Granted Dec 13, 2016·2 cites·9 claims
- 1979US7432289B25-Acylamino-1,1′-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitorsGLAXO GROUP LTD·Filed 2002·Granted Oct 7, 2008·14 cites·13 claims
- 2079US6177419B1Bipyridine manganese complexesEUKARION INC·Filed 1999·Granted Jan 23, 2001·42 cites·22 claims
- 2178US10246447B23-(6-chloro-3-oxo-3,4-dihydro-(2H)-1,4-benzoxazin-4-yl) propanoic acid derivatives and their use as KMO inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Apr 2, 2019·2 cites·8 claims
- 2278US7396843B25′-carbamoyl-1,1′-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitorsGLAXO GROUP LTD·Filed 2002·Granted Jul 8, 2008·12 cites·20 claims
- 2376US7425555B2Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitorsSMITHKLINE BEECHAM CORP·Filed 2003·Granted Sep 16, 2008·13 cites·16 claims
- 2476US7166631B2Benzo[f]isoindole derivatives with affinity to the EP4 receptorGLAXO GROUP LTD·Filed 2002·Granted Jan 23, 2007·6 cites·6 claims
- 2574US11767333B2Benzimidamides compounds comprising an oxaborinin ringINST NAT SANTE RECH MED·Filed 2022·Granted Sep 26, 2023·0 cites·19 claims
- 2670US9127003B22-(azaindol-2-yl)benzimidazoles as PAD4 inhibitorsATKINSON STEPHEN JOHN·Filed 2012·Granted Sep 8, 2015·2 cites·14 claims
- 2770US8252818B2Nicotinamide derivatives useful as P38 inhibitorsASTON NICOLA MARY·Filed 2010·Granted Aug 28, 2012·1 cites·2 claims
- 2870US7572790B2Biphenyl carboxylic amide p38 kinase inhibitorsSMITHKLINE BEECHAM CORP·Filed 2004·Granted Aug 11, 2009·5 cites·15 claims
- 2969US8575204B2Nicotinamide derivates useful as P38 inhibitorsASTON NICOLA MARY·Filed 2010·Granted Nov 5, 2013·1 cites·18 claims
- 3068US7838540B23-aminocarbonyl, 6-phenyl substituted pyridine-1-oxides as p38 kinase inhibitorsGLAXOSMITHKLINE LLC·Filed 2004·Granted Nov 23, 2010·3 cites·13 claims
- 3163US6924297B2Naphathalene derivatives which bind to the EP4 receptorSMITHKLINE BEECHAM CORP·Filed 2001·Granted Aug 2, 2005·2 cites·13 claims
- 3262US10815218B2Benzoimidazole derivatives as PAD4 inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2019·Granted Oct 27, 2020·0 cites·12 claims
- 3358US10611756B2Method of treating pancreatitis using 1,4-benzoxazine derivativesGLAXOSMITHKLINE IP DEV LTD·Filed 2019·Granted Apr 7, 2020·0 cites·11 claims
- 3457US10273232B23-(6-alkoxy-5-chlorobenzo[D]isoxazol-3-YL)propanoic acid useful as kynurenine monooxygenase inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Granted Apr 30, 2019·0 cites·24 claims
- 3556US5770598AHeterocyclic compoundsUNIV CARDIFF·Filed 1995·Granted Jun 23, 1998·8 cites·7 claims
- 3655US2007088068A1Benzo[F]Isoindole Derivatives With Affinity To The EP4 ReceptorCONGREVE MILES S·Filed 2006·Application pending·0 cites
- 3753US2007142476A1Biphenyl-Derivatives as p38 Kinase InhibitorsGLAXO GROUP LTD·Filed 2007·Application pending·0 cites
- 3853US2007112046A12'-Methyl-5'-(1,3,4-Oxadiazol-2-yl)-1,1'-Biphenyl-4-Carboxamide Derivatives and Their Use As P38 Kinase InhibitorsGLAXO GROUP LTD·Filed 2006·Application pending·0 cites
- 3952US2019100517A1CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Application pending·0 cites
- 4045US2018127405A1CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Application pending·0 cites
- 4144US10407407B2Benzoimidazole derivatives as PAD4 inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Sep 10, 2019·0 cites·16 claims
- 4244US2008214623A1N-(2,2-Dimethylpropyl)-6- -3-PyridinecarboxamideCHANDI AMRIK·Filed 2006·Application pending·0 cites
- 4344US2008004295A1Novel compoundsGORE PAUL M·Filed 2006·Application pending·0 cites
- 4442US2005065195A1Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitorsFiled 2002·Application pending·0 cites
- 4537US2007161673A1P38 kinase inhibitorsBARKER MICHAEL D·Filed 2005·Application pending·0 cites
- 4635US2009023725A1Fused Heteroaryl Derivatives for Use as P38 Kinase InhibitorsBAMBOROUGH PAUL·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ann Louise Walker files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →